Skip to main content

News Archive

News Archive - School of Medicine

Universal Gut Microbiome-Derived Signature Predicts Cirrhosis

June 30, 2020

UC San Diego School of Medicine researchers report that stool microbiomes of NAFLD patients are distinct enough to potentially be used to accurately predict which persons with NAFLD are at greatest risk for having cirrhosis.

Poseidon Innovation Announces Funding for Three UC San Diego Researchers

June 26, 2020

UC San Diego and Deerfield Management created Poseidon Innovation to support researchers working to advance disease-curing therapeutics by funding early stage projects and expediting the drug-development cycle. Poseidon announces it is funding three researchers.

Asymptomatic Testing Central to UC San Diego’s Return to Learn for Fall Quarter

June 25, 2020

The University of California San Diego today announced the next step in its Return to Learn program, which will guide an incremental repopulation of the campus while offering broad, asymptomatic testing for faculty, staff and students on a recurring basis to detect the presence of SARS-CoV-2, the no

Supercomputer Simulations Show How DNA Prepares Itself for Repair

June 25, 2020

Researchers from Harvard University and the University of Texas Medical Branch at Galveston recently used the Comet supercomputer at the San Diego Supercomputer Center at the University of California San Diego to uncover the novel ways in which DNA prepares itself for repair.

One-Time Treatment Generates New Neurons, Eliminates Parkinson’s Disease in Mice

June 24, 2020

UC San Diego researchers have discovered that a single treatment to inhibit a gene called PTB in mice converts native astrocytes, brain support cells, into neurons that produce the neurotransmitter dopamine. As a result, the mice’s Parkinson’s disease symptoms disappear.

Immune Cells Infiltrating Tumors May Play Bigger Cancer Role Than Previously Thought

June 22, 2020

UC San Diego researchers uncovered in mice how IRE1α, a molecule involved in cells’ response to stress, determines whether macrophages promote inflammation in the tumor microenvironment. Inflammation is known to promote tumor growth, making IRE1α an attractive target for drug development.

SDSC Sherlock Cloud adds Google Cloud Platform to Extend its Multi-Cloud Service

June 16, 2020

SDSC's Sherlock Division has expanded its multi-Cloud solution, Sherlock Cloud, to include the Google Cloud Platform (GCP) in addition to AWS and Microsoft Azure.

Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease

June 16, 2020

A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.

Longitudinal Study of Brain Aging and Cognitive Change Receives $19 Million Grant

June 15, 2020

Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.

Putting ‘Super’ in Natural Killer Cells

June 11, 2020

Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
Category navigation with Social links